These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 19265619

  • 1. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL, Schaefer JT, Dahiya A.
    Dermatol Online J; 2008 Dec 15; 14(12):6. PubMed ID: 19265619
    [Abstract] [Full Text] [Related]

  • 2. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM, Da Fonseca Porto A.
    Parasite Immunol; 2004 Dec 15; 26(11-12):487-97. PubMed ID: 15771684
    [Abstract] [Full Text] [Related]

  • 3. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L, McCarthy AE, Faught C.
    Int J Infect Dis; 2009 Nov 15; 13(6):e501-3. PubMed ID: 19501008
    [Abstract] [Full Text] [Related]

  • 4. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
    Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR.
    Clin Infect Dis; 2005 Jul 01; 41(1):e5-8. PubMed ID: 15937753
    [Abstract] [Full Text] [Related]

  • 5. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J, Schwarz U, Duwe S, Ellerbrok H, Poggensee G, Pauli G.
    Dtsch Med Wochenschr; 2005 Apr 22; 130(16):1007-10. PubMed ID: 15830313
    [Abstract] [Full Text] [Related]

  • 6. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C, Kinoshita K, Nozaki Y, Funauchi M.
    BMC Infect Dis; 2020 Jul 02; 20(1):470. PubMed ID: 32615937
    [Abstract] [Full Text] [Related]

  • 7. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J.
    Am J Trop Med Hyg; 2006 Feb 02; 74(2):246-9. PubMed ID: 16474078
    [Abstract] [Full Text] [Related]

  • 8. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
    Porto MA, Alcântara LM, Leal M, Castro N, Carvalho EM.
    Am J Trop Med Hyg; 2005 Feb 02; 72(2):124-5. PubMed ID: 15741545
    [Abstract] [Full Text] [Related]

  • 9. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA, Maclean JD, Fleckenstein L, Greenaway C.
    Am J Trop Med Hyg; 2005 Nov 02; 73(5):911-4. PubMed ID: 16282302
    [Abstract] [Full Text] [Related]

  • 10. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
    Benvenuti F, Carrascosa JM, Boada A, Ferrandiz C.
    Eur J Dermatol; 2009 Nov 02; 19(4):404-5. PubMed ID: 19467975
    [No Abstract] [Full Text] [Related]

  • 11. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N.
    Mikrobiyol Bul; 2009 Jan 02; 43(1):169-77. PubMed ID: 19334396
    [Abstract] [Full Text] [Related]

  • 12. Cutaneous Strongyloides stercoralis infection: an unusual presentation.
    Ly MN, Bethel SL, Usmani AS, Lambert DR.
    J Am Acad Dermatol; 2003 Aug 02; 49(2 Suppl Case Reports):S157-60. PubMed ID: 12894109
    [Abstract] [Full Text] [Related]

  • 13. Disseminated Strongyloidiasis.
    Mileo Bacelar Guerreiro F, Tavares Sodré C, Brandão Pavan L, Feijó Barroso P, Carvalho Quintella D, Cuzzi T, Ramos-E-Silva M.
    Acta Dermatovenerol Croat; 2018 Dec 02; 26(4):333-336. PubMed ID: 30665485
    [Abstract] [Full Text] [Related]

  • 14. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R, Joseph AJ, Chacko A.
    Trop Gastroenterol; 2007 Dec 02; 28(4):176-7. PubMed ID: 18416349
    [Abstract] [Full Text] [Related]

  • 15. Strongyloides stercoralis colitis in a patient positive for human T-cell leukaemia virus with rheumatoid arthritis during an anti-rheumatic therapy: a case report.
    Hashiba Y, Umekita K, Minami H, Kawano A, Nagayasu E, Maruyama H, Hidaka T, Okayama A.
    Mod Rheumatol Case Rep; 2021 Jan 02; 5(1):16-21. PubMed ID: 32772699
    [Abstract] [Full Text] [Related]

  • 16. Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output.
    De Souza JN, Soares BNRR, Goes LL, Lima CS, Barreto NMPV, Jacobina BS, Gonçalves N, Teixeira MCA, Galvão-Castro B, Grassi MFR, Soares NM.
    Am J Trop Med Hyg; 2018 Dec 02; 99(6):1583-1586. PubMed ID: 30277207
    [Abstract] [Full Text] [Related]

  • 17. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.
    Martin SJ, Cohen PR, MacFarlane DF, Grossman ME.
    Skinmed; 2011 Dec 02; 9(3):199-202. PubMed ID: 21675505
    [Abstract] [Full Text] [Related]

  • 18. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
    Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W.
    Am J Trop Med Hyg; 2008 Dec 02; 79(6):853-5. PubMed ID: 19052292
    [Abstract] [Full Text] [Related]

  • 19. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
    Salles F, Bacellar A, Amorim M, Orge G, Sundberg M, Lima M, Santos S, Porto A, Carvalho E.
    Trans R Soc Trop Med Hyg; 2013 Aug 02; 107(8):526-9. PubMed ID: 23843560
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary strongyloidiasis.
    Jayaprakash B, Sandhya S, Anithakumari K.
    J Assoc Physicians India; 2009 Jul 02; 57():535-6. PubMed ID: 20329418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.